Mersana

MRSN NASDAQ
2.800
+0.090
+3.32%
Opening 14:42 08/21 EDT
Open
2.770
Prev Close
2.710
High
2.800
Low
2.689
Volume
106.64K
Avg Vol (3M)
234.67K
52 Week High
15.93
52 Week Low
2.611
% Turnover
0.22%
Market Cap
133.87M
1D
5D
1M
3M
1Y
5Y

Company Profile

Mersana Therapeutics, Inc. is a biotechnology company. The Company is focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies.
MORE >

Recently

Name
Price
%Change